Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study

    The PERI-DYS study aims to characterize two groups of patients with dyslipidaemia at very high CV risk: PCSK9i receivers and patients qualifying for but not receiving PCSK9i.

    Ulrich Laufs, Andreas L. Birkenfeld, Uwe Fraass in Cardiovascular Drugs and Therapy (2024)

  2. Article

    Open Access

    Apheresis: What Should a Clinician Know?

    Apheresis is a treatment option for severe dyslipidemia which has been introduced approximately 40 years ago to clinical practice. This article reviews recent apheresis research progresses, including apheresis...

    Klaus G. Parhofer in Current Atherosclerosis Reports (2023)

  3. No Access

    Article

    Hypercholesterolemia diagnosis, treatment patterns and target achievement in patients with acute coronary syndromes in Germany

    Patients who experience an acute coronary syndrome (ACS) are at high risk of further cardiovascular events. Long-term treatment of cardiovascular risk factors, such as hyperlipidemia, is critical to prevent pr...

    Anselm K. Gitt, Klaus G. Parhofer, Ulrich Laufs in Clinical Research in Cardiology (2023)

  4. Article

    Open Access

    Oral Lipid-Lowering Treatments Beyond Statins: Too Old and Outdated or Still Useful?

    For many years, the lipid-lowering armamentarium consisted of statins and/or ezetimibe and/or bile acid sequestrants and/or fibrates. Now, with the availability of new drugs mostly injectables, the field has c...

    Klaus G. Parhofer in Current Atherosclerosis Reports (2021)

  5. Article

    Open Access

    PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice

    Several lipid guidelines recommend that proprotein convertase subtilisin/kexin type 9 inhibitors should be considered for patients with atherosclerotic cardiovascular disease who are inadequately treated with ...

    Klaus G. Parhofer, Berndt von Stritzky, Nicole Pietschmann in Drugs - Real World Outcomes (2019)

  6. No Access

    Article

    Positionspapier zur Lipidtherapie bei Patienten mit Diabetes mellitus

    Klaus G. Parhofer, Andreas L. Birkenfeld, Wilhelm Krone, Michael Lehrke in Der Diabetologe (2019)

  7. Article

    Open Access

    Current Role of Lipoprotein Apheresis

    Lipoprotein apheresis is a very efficient but time-consuming and expensive method of lowering levels of low-density lipoprotein cholesterol, lipoprotein(a)) and other apoB containing lipoproteins, including tr...

    Gilbert Thompson, Klaus G. Parhofer in Current Atherosclerosis Reports (2019)

  8. Article

    Open Access

    HDL cholesterol: reappraisal of its clinical relevance

    While several lines of evidence prove that elevated concentrations of low-density lipoproteins (LDL) causally contribute to the development of atherosclerosis and its clinical consequences, high-density lipopr...

    Winfried März, Marcus E. Kleber, Hubert Scharnagl in Clinical Research in Cardiology (2017)

  9. Article

    Open Access

    Predictors of glucose control in children and adolescents with type 1 diabetes: results of a cross-sectional study in Cameroon

    In sub-Saharan Africa the prognosis of children with type 1 diabetes is poor. Many are not diagnosed and those diagnosed have a dramatically reduced life expectancy (less than one year). The purpose of this st...

    Loveline L. Niba, Benedikt Aulinger, Wilfred F. Mbacham in BMC Research Notes (2017)

  10. No Access

    Article

    Whole-Body MR Imaging Including Angiography: Predicting Recurrent Events in Diabetics

    Whether whole-body MRI can predict occurrence of recurrent events in patients with diabetes mellitus.

    Robert C. Bertheau, Fabian Bamberg, Elena Lochner in European Radiology (2016)

  11. Article

    Open Access

    Interleukin-6 predicts inflammation-induced increase of Glucagon-like peptide-1 in humans in response to cardiac surgery with association to parameters of glucose metabolism

    Glucagon-like peptide-1 (GLP-1) is an incretin hormone, which gets secreted in response to nutritional stimuli from the gut mediating glucose-dependent insulin secretion. Interestingly, GLP-1 was recently foun...

    Corinna Lebherz, Florian Kahles, Katja Piotrowski in Cardiovascular Diabetology (2016)

  12. Article

    Open Access

    The stool microbiota of insulin resistant women with recent gestational diabetes, a high risk group for type 2 diabetes

    The gut microbiota has been linked to metabolic diseases. However, information on the microbiome of young adults at risk for type 2 diabetes (T2D) is lacking. The aim of this cross-sectional analysis was to in...

    Marina Fugmann, Michaela Breier, Marietta Rottenkolber in Scientific Reports (2015)

  13. Article

    Open Access

    Height-obesity relationship in school children in Sub-Saharan Africa: results of a cross-sectional study in Cameroon

    In developed nations, taller children exhibit a greater propensity to overweight/obesity. This study investigates whether this height-adiposity relationship holds true for Cameroon children using two parameter...

    Lifoter K Navti, Uta Ferrari, Emmanuel Tange, Klaus G Parhofer in BMC Research Notes (2015)

  14. No Access

    Article

    Stärken und Grenzen randomisierter Studien zur Lipidtherapie

    Zunehmend enden Interventionsstudien zu wesentlichen therapeutischen Fragestellungen mit einem nicht signifikanten Ergebnis für den primären Endpunkt. Das prägt auch das Bild der randomisierten Studien im Bere...

    Eberhard Windler, Prof. Dr. med. Gerald Klose, Klaus G. Parhofer in CardioVasc (2014)

  15. Article

    Open Access

    Contribution of socioeconomic status, stature and birth weight to obesity in Sub-Saharan Africa: cross-sectional data from primary school-age children in Cameroon

    The pattern of obesity in relation to socioeconomic status is of public health concern. This study investigates whether the association between height and obesity in children is affected by their socioeconomic...

    Lifoter K Navti, Uta Ferrari, Emmanuel Tange in BMC Public Health (2014)

  16. No Access

    Article

    New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk

    After the publication of the new guidelines of the European Society of Cardiology and the European Atherosclerosis Society for the prevention and treatment of dyslipidemias (Eur Heart J 32:1769–1818, 2011; Eur...

    Gerald Klose, Frank Ulrich Beil, Hans Dieplinger in Wiener klinische Wochenschrift (2014)

  17. Article

    Open Access

    Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans

    GLP-1 is an incretine hormone which gets secreted from intestinal L-cells in response to nutritional stimuli leading to pancreatic insulin secretion and suppression of glucagon release. GLP-1 further inhibits ...

    Katja Piotrowski, Melanie Becker, Julia Zugwurst in Cardiovascular Diabetology (2013)

  18. Article

    Open Access

    Effect of sleeve gastrectomy on postprandial lipoprotein metabolism in morbidly obese patients

    Obesity is associated with abnormal fasting and postprandial lipids, which may link obesity with atherosclerosis. We explored fasting and postprandial lipids in morbidly obese patients treated with sleeve gast...

    Elisa Waldmann, Thomas P Hüttl, Burkhard Göke in Lipids in Health and Disease (2013)

  19. Article

    Open Access

    Metabolic syndrome predicts vascular changes in whole body magnetic resonance imaging in patients with long standing diabetes mellitus

    Although diabetic patients have an increased rate of cardio-vascular events, there is considerable heterogeneity with respect to cardiovascular risk, requiring new approaches to individual cardiovascular risk ...

    Hannes M Findeisen, Sabine Weckbach, Renée G Stark in Cardiovascular Diabetology (2010)

  20. Article

    Open Access

    Relative roles of the different Pax6 domains for pancreatic alpha cell development

    The transcription factor Pax6 functions in the specification and maintenance of the differentiated cell lineages in the endocrine pancreas. It has two DNA binding domains, the paired domain and the homeodomain...

    Petra Dames, Ramona Puff, Michaela Weise, Klaus G Parhofer in BMC Developmental Biology (2010)

previous disabled Page of 2